NCT03009318

MRS and 11C-methionine PET/CT in the Diagnosis of Glioma

Combination of 11C-MET PET and MRS in the Diagnosis of Glioma.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Huashan Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

MET PET and MRS are often performed as imaging tool for the differential diagnosis of gliomas. But both techniques have limitations causing misdiagnosis; thus, the investigators tried to combine these two imaging tools to study whether the combination of MET PET and MRS could raise the diagnosis ability of the radiological diagnosis of gliomas.

Conditions

• Glioma

Interventions

Type	Name	Description
OTHER	tumors are confirmed by surgery and pathology	Each patient undergoes both MRS and MET PET scan before surgery. The lesion will be considered as a glioma when either MRS or MET PET results indicated the diagnosis. Pathologic diagnosis will be performed to confirm the final diagnosis.

Timeline

• Start date: 2012-01-01
• Primary completion: 2016-09-01
• Completion: 2017-12-01
• First posted: 2017-01-04
• Last updated: 2018-04-09

Locations

1 site across 1 country: China